AngioDynamics: Discounted Sales Multiple With Real Growth Engines

Core Viewpoint - The analysis indicates a positive outlook for AngioDynamics, Inc. (NASDAQ: ANGO) based on its growing portfolio of medical technology products [1] Company Summary - AngioDynamics is recognized for its focus on medical technology, particularly in the small- to mid-cap sector, which is often overlooked by investors [1] - The company has been rated a Buy, suggesting confidence in its growth potential and market position [1] Industry Context - The analysis occasionally includes insights on large-cap companies to provide a broader perspective on equity markets, indicating a comprehensive approach to market research [1]